Glaukos Corporation (GKOS) Financials

GKOS Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 893.3 million 222.4 million
Dec. 31, 2025 893.5 million 237.3 million
Sept. 30, 2025 999.4 million 229.8 million
June 30, 2025 987.0 million 221.8 million

GKOS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -16.5 million 19.1 million
Dec. 31, 2025 3.9 million 17.3 million
Sept. 30, 2025 -11.7 million 14.9 million
June 30, 2025 5.8 million 18.0 million

GKOS Net Income

No data available :(

GKOS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 276.7 million 103.1 million 103.1 million
Dec. 31, 2025 278.8 million 35.8 million 103.9 million
Sept. 30, 2025 273.7 million - 104.3 million
June 30, 2025 274.8 million - 105.0 million

GKOS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 58.0 million
Dec. 31, 2025 57.5 million
Sept. 30, 2025 57.4 million
June 30, 2025 57.2 million

GKOS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 4.0 million 44.1 million 92.9 million -
Dec. 31, 2025 2.9 million 43.7 million 94.7 million -
Sept. 30, 2025 1.6 million 38.1 million 83.0 million -
June 30, 2025 1.2 million 36.5 million 83.4 million -

GKOS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 150.6 million 33.3 million
Dec. 31, 2025 143.1 million 31.8 million
Sept. 30, 2025 133.5 million 28.8 million
June 30, 2025 124.1 million 26.9 million

GKOS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GKOS

Price: $129.28

52 week price:
73.16
148.11

Earnings Per Share: -3.19 USD

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 62314

Ebitda: 2.3 million

Market Capitalization: 7.3 billion

Links: